NCT00085956View on ClinicalTrials.gov

Effects of Arzoxifene on Bone Mass and the Uterus

PHASE3CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

February 28, 2007

Conditions

Postmenopausal Bone Loss

Interventions

DRUG

Arzoxifene

DRUG

Placebo

Trial Locations (1)

92103

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Diego

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00085956 - Effects of Arzoxifene on Bone Mass and the Uterus | Biotech Hunter | Biotech Hunter